Proteolix: A "ME-TOO" SUCCES

• Autores: Larry Lasky, Victoria Chang
• Localización: California management review, ISSN 0008-1256, Vol. 55, Nº 2, 2013, págs. 125-139
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • In an industry rife with failures, Proteolix, a biotechnology company, was a rare success. The Proteolix case provides a compelling example of a biotech company that has chosen a "me-too" strategy, a less risky strategy than the strategy of discovering a drug for a novel target. However, even me-too drug strategies in the biotech industry face an uphill battle.